This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blaney, J. E.
Right arrow Articles by Whitehead, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blaney, J. E., Jr.
Right arrow Articles by Whitehead, S. S.

 Previous Article  |  Next Article 

Journal of Virology, May 2005, p. 5516-5528, Vol. 79, No. 9
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.9.5516-5528.2005

Recombinant, Live-Attenuated Tetravalent Dengue Virus Vaccine Formulations Induce a Balanced, Broad, and Protective Neutralizing Antibody Response against Each of the Four Serotypes in Rhesus Monkeys

Joseph E. Blaney Jr.,* Jennifer M. Matro, Brian R. Murphy, and Stephen S. Whitehead

Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892

Received 15 October 2004/ Accepted 10 December 2004

Three tetravalent vaccine (TV) formulations of previously described monovalent dengue (DEN) virus vaccine candidates were compared to a tetravalent formulation of wild-type DEN viruses (T-wt) for replication in SCID mice transplanted with human liver cells (SCID-HuH-7) or for replication and immunogenicity in rhesus monkeys. TV-1 consists of recombinant DEN1, -2, -3, and -4, each with a 30-nucleotide deletion in the 3' untranslated region ({Delta}30). TV-2 consists of rDEN1{Delta}30, rDEN4{Delta}30, and two antigenic chimeric viruses, rDEN2/4{Delta}30 and rDEN3/4{Delta}30, both also bearing the {Delta}30 mutation. TV-3 consists of rDEN1{Delta}30, rDEN2{Delta}30, rDEN4{Delta}30, and a 10-fold higher dose of rDEN3/4{Delta}30. TV-1 and TV-2 were attenuated in SCID-HuH-7 mice with minimal interference in replication among the virus components. TV-1, -2, and -3 were attenuated in rhesus monkeys as measured by duration and peak of viremia. Each monkey immunized with TV-1 and TV-3 seroconverted to the four DEN components by day 28 with neutralization titers ranging from 1:52 to 1:273 and 1:59 to 1:144 for TV-1 and TV-3, respectively. TV-2 induced low antibody titers to DEN2 and DEN3, but a booster immunization after 4 months increased the neutralizing antibody titers to greater than 1:100 against each serotype and elicited broad neutralizing activity against 19 of 20 DEN subtypes. A single dose of TV-2 induced protection against wild-type DEN1, DEN3, and DEN4 challenge, but not DEN2. However, two doses of TV-2 or TV-3 induced protection against DEN2 challenge. Two tetravalent formulations, TV-2 and TV-3, possess properties of a successful DEN vaccine and can be considered for evaluation in clinical trials.

* Corresponding author. Mailing address: NIH, NIAID, LID Twinbrook III, Room 3W-13, 12735 Twinbrook Parkway, MSC 8133, Bethesda, MD 20892-8133. Phone: (301) 594-1630. Fax: (301) 480-4509. E-mail: jblaney{at}niaid.nih.gov.

Journal of Virology, May 2005, p. 5516-5528, Vol. 79, No. 9
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.9.5516-5528.2005




This article has been cited by other articles:

  • Suzuki, R., Winkelmann, E. R., Mason, P. W. (2009). Construction and Characterization of a Single-Cycle Chimeric Flavivirus Vaccine Candidate That Protects Mice against Lethal Challenge with Dengue Virus Type 2. J. Virol. 83: 1870-1880 [Abstract] [Full Text]  
  • Carter, J. R., Fraser, T. S., Fraser, M. J. Jr (2008). Examining the relative activity of several dicistrovirus intergenic internal ribosome entry site elements in uninfected insect and mammalian cell lines. J. Gen. Virol. 89: 3150-3155 [Abstract] [Full Text]  
  • Raviprakash, K., Wang, D., Ewing, D., Holman, D. H., Block, K., Woraratanadharm, J., Chen, L., Hayes, C., Dong, J. Y., Porter, K. (2008). A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus. J. Virol. 82: 6927-6934 [Abstract] [Full Text]  
  • Vasilakis, N., Durbin, A. P., da Rosa, A. P. A. T., Munoz-Jordan, J. L., Tesh, R. B., Weaver, S. C. (2008). Antigenic Relationships between Sylvatic and Endemic Dengue Viruses. Am J Trop Med Hyg 79: 128-132 [Abstract] [Full Text]  
  • Sariol, C. A., Munoz-Jordan, J. L., Abel, K., Rosado, L. C., Pantoja, P., Giavedoni, L., Rodriguez, I. V., White, L. J., Martinez, M., Arana, T., Kraiselburd, E. N. (2007). Transcriptional Activation of Interferon-Stimulated Genes but Not of Cytokine Genes after Primary Infection of Rhesus Macaques with Dengue Virus Type 1. CVI 14: 756-766 [Abstract] [Full Text]  
  • Holman, D. H., Wang, D., Raviprakash, K., Raja, N. U., Luo, M., Zhang, J., Porter, K. R., Dong, J. Y. (2007). Two Complex, Adenovirus-Based Vaccines That Together Induce Immune Responses to All Four Dengue Virus Serotypes. CVI 14: 182-189 [Abstract] [Full Text]  
  • KHANAM, S., ETEMAD, B., KHANNA, N., SWAMINATHAN, S. (2006). INDUCTION OF NEUTRALIZING ANTIBODIES SPECIFIC TO DENGUE VIRUS SEROTYPES 2 AND 4 BY A BIVALENT ANTIGEN COMPOSED OF LINKED ENVELOPE DOMAINS III OF THESE TWO SEROTYPES. Am J Trop Med Hyg 74: 266-277 [Abstract] [Full Text]  
  • Krebs, K. C., Jin, Z., Rudersdorf, R., Hughes, A. L., O'Connor, D. H. (2005). Unusually High Frequency MHC Class I Alleles in Mauritian Origin Cynomolgus Macaques. J. Immunol. 175: 5230-5239 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»